GM Advisory Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$942K Sell
3,188
-185
-5% -$55K 0.04% 172
2025
Q4
$921K Buy
3,373
+195
+6% +$53K 0.04% 171
2025
Q3
$859K Buy
3,178
+6
+0.2% +$1.63K 0.04% 160
2025
Q2
$874K Hold
3,172
0.04% 155
2025
Q1
$842K Buy
3,172
+18
+0.6% +$4.44K 0.05% 142
2024
Q4
$732K Hold
3,154
0.04% 145
2024
Q3
$696K Hold
3,154
0.04% 141
2024
Q2
$620K Hold
3,154
0.04% 143
2024
Q1
$679K Hold
3,154
0.05% 134
2023
Q4
$664K Buy
3,154
+402
+15% +$85.8K 0.05% 122
2023
Q3
$551K Hold
2,752
0.05% 116
2023
Q2
$510K Sell
2,752
-108
-4% -$20K 0.04% 124
2023
Q1
$548K Sell
2,860
-42
-1% -$7.59K 0.05% 117
2022
Q4
$488K Hold
2,902
0.05% 114
2022
Q3
$514K Buy
+2,902
New +$574K 0.06% 114

Other funds holding CME

GM Advisory Group's CME Position: Q1 2026 in Review

GM Advisory Group reduced its CME Group (CME) stake by 5.5% in Q1 2026, selling an estimated $55K and leaving 3,188 shares worth $942K. The position accounts for 0.04% of the portfolio, ranked #172.

GM Advisory Group first reported a position in CME in Q3 2022 and has held it in 15 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • GM Advisory Group held 3,188 shares of CME Group worth $942K as of Q1 2026.
  • GM Advisory Group sold 185 CME Group shares in Q1 2026, an estimated $55K.
  • CME Group made up 0.04% of GM Advisory Group's portfolio in Q1 2026, its #172 holding.
  • GM Advisory Group first reported a position in CME Group in Q3 2022 and has held it in 15 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.